Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)
Genmab
Genmab
Bayer
Immatics US, Inc.
Chengdu Zenitar Biomedical Technology Co., Ltd
ModernaTX, Inc.
Prescient Therapeutics, Ltd.
OncoNano Medicine, Inc.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Novelwise Pharmaceutical Corporation
M.D. Anderson Cancer Center
Treeline Biosciences, Inc.
City of Hope Medical Center
Biogen
City of Hope Medical Center
Yale University
University of Aarhus
Vastra Gotaland Region
Stanford University
University College, London
Melanoma and Skin Cancer Trials Limited
BeiGene
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Zai Lab (Hong Kong), Ltd.
Bristol-Myers Squibb
Nektar Therapeutics
Atara Biotherapeutics
Thomas Jefferson University
Roswell Park Cancer Institute
Peter MacCallum Cancer Centre, Australia
University of Kansas Medical Center
Provectus Pharmaceuticals
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center
Incyte Corporation
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Celgene
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Chicago
University Hospital, Geneva
Wake Forest University Health Sciences